User profiles for Andrew Pekosz

Andrew Pekosz

Professor of Molecular Microbiology, Johns Hopkins Bloomberg School of Public Health
Verified email at jhsph.edu
Cited by 17193

[HTML][HTML] Efficacy of antibodies and antiviral drugs against Covid-19 Omicron variant

…, M Saito, E Adachi, D Sullivan, A Pekosz… - … England Journal of …, 2022 - Mass Medical Soc
Monoclonal Antibody and Antiviral Activity against Omicron Investigators assessed the in
vitro activities of seven monoclonal antibodies and three antiviral drugs against Covid-19 …

[HTML][HTML] Efficacy of antibodies and antiviral drugs against Omicron BA. 2.12. 1, BA. 4, and BA. 5 subvariants

…, H Van Bakel, EM Sordillo, A Pekosz… - … England Journal of …, 2022 - Mass Medical Soc
Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5
Subvariants | NEJM Skip to main content NEJM Group Follow Us Facebook Twitter Instagram …

[HTML][HTML] Deployment of convalescent plasma for the prevention and treatment of COVID-19

…, M Joyner, JP Henderson, A Pekosz… - The Journal of …, 2020 - Am Soc Clin Investig
Severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2), the cause of coronavirus
disease 2019 (COVID-19), has spurred a global health crisis. To date, there are no proven …

Antigen-based testing but not real-time polymerase chain reaction correlates with severe acute respiratory syndrome coronavirus 2 viral culture

A Pekosz, V Parvu, M Li, JC Andrews… - Clinical Infectious …, 2021 - academic.oup.com
Background Individuals can test positive for severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) by molecular assays following the resolution of their clinical disease. …

[HTML][HTML] Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population

SL Klein, A Pekosz, HS Park, RL Ursin… - The Journal of …, 2020 - Am Soc Clin Investig
Convalescent plasma is a leading treatment for coronavirus disease 2019 (COVID-19), but
there is a paucity of data identifying its therapeutic efficacy. Among 126 potential …

IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses

…, A García-Sastre, DA Leib, A Pekosz… - Proceedings of the …, 2007 - National Acad Sciences
Type I interferons (IFNs) play an essential role in the host response to viral infection through
the induction of numerous IFN-stimulated genes (ISGs), including important antiviral …

The Xs and Y of immune responses to viral vaccines

SL Klein, A Jedlicka, A Pekosz - The Lancet infectious diseases, 2010 - thelancet.com
The biological differences associated with the sex of an individual are a major source of
variation, affecting immune responses to vaccination. Compelling clinical data illustrate that men …

[HTML][HTML] Early outpatient treatment for Covid-19 with convalescent plasma

…, SN Baksh, O Laeyendecker, A Pekosz… - … England Journal of …, 2022 - Mass Medical Soc
Background Polyclonal convalescent plasma may be obtained from donors who have
recovered from coronavirus disease 2019 (Covid-19). The efficacy of this plasma in preventing …

[HTML][HTML] SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals

…, D Sullivan, A Casadevall, A Pekosz… - The Journal of …, 2021 - Am Soc Clin Investig
Characterization of the T cell response in individuals who recover from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is critical to understanding its …

Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins

J Zhang, A Pekosz, RA Lamb - Journal of virology, 2000 - Am Soc Microbiol
Influenza viruses encoding hemagglutinin (HA) and neuraminidase (NA) glycoproteins with
deletions in one or both cytoplasmic tails (HAt− or NAt−) have a reduced association with …